One of our valued FTMIG members connects us with Guy Chamberland, Interim CEO of Tetra Bio-Pharma, to have an interesting discussion on TBP's trailblazing progress, recent product approvals, and their role in the fight against opioid use! (TSXV: TBP) #TBP
TUNE IN every Wednesday from 1-3pm EST on Midas Letter (midasletter.com) where we bring you the most current interviews, special guests, T.A., and discussions on the most interesting companies in the hottest sectors.
Built by investors, for investors.
Be in the know and FOLLOW THE MONEY!